Differences Between Pediatric Acute Myocarditis Related and Unrelated to SARS-CoV-2

Vladislav A Vukomanovic1,2, Stasa Krasic1, Sergej Prijic1,2

  • 1From the Cardiology Department, Mother and Child Health Institute of Serbia, Belgrade, Serbia.

Insights

Children with acute myocarditis (AM) related to SARS-CoV-2 showed distinct symptoms and faster recovery. AM unrelated to SARS-CoV-2 was associated with more severe outcomes in pediatric patients.

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Acute myocarditis (AM) is myocardial inflammation.
  • Distinguishing AM related to SARS-CoV-2 from other causes is crucial for pediatric care.
  • COVID-19 has emerged as a significant factor in pediatric cardiovascular conditions.

Purpose of the Study:

  • To conduct a comparative analysis of acute myocarditis (AM) in children.
  • To identify differences between AM associated with SARS-CoV-2 and AM from other causes.
  • To evaluate clinical presentation, laboratory findings, and outcomes in pediatric AM patients.

Main Methods:

  • Retrospective study of pediatric patients diagnosed with AM between January 2018 and November 2020.
  • Comparison of clinical characteristics, laboratory markers (cTnI, platelets, CRP, BNP), and treatment strategies.
  • Analysis of patient outcomes, including adverse events and recovery of cardiac function.

Main Results:

  • Seven of 24 pediatric patients had AM related to SARS-CoV-2, presenting with abdominal pain, headache, rash, and conjunctivitis.
  • AM unrelated to SARS-CoV-2 was more frequently associated with fulminant myocarditis and adverse outcomes (e.g., death, dilated cardiomyopathy).
  • SARS-CoV-2-related AM showed lower cTnI and platelets, higher CRP, shorter inotropic support duration, and faster left ventricle systolic function recovery.

Conclusions:

  • Pediatric AM related to SARS-CoV-2 exhibits a distinct clinical profile, including a polymorphic presentation and higher CRP levels.
  • Patients with SARS-CoV-2-associated AM experienced shorter inotropic drug requirements and demonstrated prompt recovery of left ventricular systolic function.
  • AM unrelated to SARS-CoV-2 was linked to more frequent severe adverse outcomes in the pediatric population.
Abstract

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
87
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
135
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
48
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
111
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
185
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
89